Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03767894 · ClinicalTrials.gov registry record · NA

MyHand: An Active Hand Orthosis for Stroke Patients

A NA study, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
12
Enrollment target

NCT03767894: Completed NA study, sponsored by Columbia University.

NCT03767894 is a NA study that has completed, run by Columbia University. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03767894, a NA study, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

This study seeks to explore the efficacy of several control mechanisms for the device and the impact of a device training program on its utility as a neuroprosthetic and training tool for upper limb recovery.

Primary Outcome

The ARAT is a 19-item measure that assesses upper limb functioning. The ARAT is divided into 4 sub-tests (grasp, grip, pinch, and gross arm movement). Performance on each item is rated on a 4-point ordinal scale ranging from 0 (cannot perform) to 3 (normal performance). Scores on the ARAT range from 0-57 points, with higher scores indicating better performance.

Interventions

  • DEVICE EMG Band
  • DEVICE Shoulder harness

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2017-11-13
Est. Completion 2019-06-27
Phase NA
Columbia University

958 total trials

What the finished NCT03767894 record still lists

NCT03767894 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which EMG Band is the first listed.

NCT03767894 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03767894 about?

NCT03767894 is a clinical study titled "MyHand: An Active Hand Orthosis for Stroke Patients". This study seeks to explore the efficacy of several control mechanisms for the device and the impact of a device training program on its utility as a neuroprosthetic and training tool for upper limb recovery.

What is the current status of trial NCT03767894?

This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2017-11-13. Estimated completion is 2019-06-27.

What interventions are being tested in trial NCT03767894?

The interventions under investigation include: EMG Band (DEVICE), Shoulder harness (DEVICE).

Who is sponsoring clinical trial NCT03767894?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03767894's enrollment target sits among peer trials

12 1913th of 2000 higher than 74 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03767894, the US trial registry maintained by the National Library of Medicine. NCT03767894 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.